Anti-SMN complex antibodies in paediatric mixed connective tissue disease with interstitial lung disease: clinical and immunological insights
Rheumatology Advances in Practice · 15.06.2026 · 10 (3)
DOI: 10.1093/rap/rkag073 ↗Kurz gefasst
Fallbericht in der Zeitschrift Rheumatology Advances in Practice, online erschienen am 02.07.2026. Verfasst von Ann Tamura und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Labor Sciences Research, JSPS KAKENHI.
Abstract (Originalsprache)
D EAR E DITOR , MCTD is an autoimmune disorder characterized by overlapping features of SLE, SSc and PM, together with anti-U1-RNP antibodies [1]. Despite being recognized as a distinct clinical entity, MCTD displays heterogeneity in the age of onset, clinical trajectory and organ involvement. Paediatric-onset MCTD is uncommon and generally associated with low mortality; however, its diagnosis and management remain challenging [1, 2]. Although anti-U1-RNP antibodies serve as a diagnostic hallmark, they also occur in SLE and SSc, often obscuring early classification [3]. Pulmonary involvement, particularly interstitial lung disease (ILD), represents a key determinant of prognosis in MCTD [4]. ILD in paediatric patients is often under-recognized and warrants careful evaluation [5]. Recently, antibodies directed against the survival motor neuron (SMN) complex have been proposed as biomarkers linked to ILD and heightened disease activity [6]. However, the clinical
Autor:innen und Institutionen
- Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Department of Hematology and Immunology, Fukuoka Children's Hospital, Fukuoka, Japan.
ORCID-Profile: Motoshi Sonoda, Nobutaka Harada, Katsuhide Eguchi, Masataka Ishimura
Förderung
- Health and Labor Sciences Research
- JSPS KAKENHI
Zitieren
APA
Tamura, A., Sonoda, M., Park, S., Nagasawa, K., Harada, N., Kinoshita, K., Eguchi, K., Sakai, Y., & Ishimura, M. (2026). Anti-SMN complex antibodies in paediatric mixed connective tissue disease with interstitial lung disease: clinical and immunological insights. Rheumatology Advances in Practice, 10(3). https://doi.org/10.1093/rap/rkag073
Vancouver
Tamura A, Sonoda M, Park S, Nagasawa K, Harada N, Kinoshita K, et al. Anti-SMN complex antibodies in paediatric mixed connective tissue disease with interstitial lung disease: clinical and immunological insights. Rheumatology Advances in Practice. 2026;10(3). doi:10.1093/rap/rkag073
BibTeX
@article{Tamura2026,
author = {Tamura, Ann and Sonoda, Motoshi and Park, Sungyeon and Nagasawa, Kota and Harada, Nobutaka and Kinoshita, Keishiro and Eguchi, Katsuhide and Sakai, Yasunari and Ishimura, Masataka},
title = {Anti-SMN complex antibodies in paediatric mixed connective tissue disease with interstitial lung disease: clinical and immunological insights},
journal = {Rheumatology Advances in Practice},
year = {2026},
volume = {10},
number = {3},
doi = {10.1093/rap/rkag073}
}
EUVIMED